| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000034398 |
| Receipt No. | R000039215 |
| Official scientific title of the study | Effect of test food on the postprandial blood glucose level -A randomized, double blind, placebo controlled, cross-over study- |
| Date of disclosure of the study information | 2018/10/09 |
| Last modified on | 2018/10/05 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Effect of test food on the postprandial blood glucose level -A randomized, double blind, placebo controlled, cross-over study- | |
| Title of the study (Brief title) | Effect of test food on the postprandial blood glucose level | |
| Region |
|
|
| Condition | ||
| Condition | healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effect of test food on the postprandial blood glucose level of subjects |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Area under the curve (AUC) for postprandial blood glucose level |
| Key secondary outcomes | AUC for postprandial insulin level, and insulin levels and blood glucose levels at 30, 60, 90, and 120 minutes after rice ingestion |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of test food, and then intake of placebo after wash out period | |
| Interventions/Control_2 | Intake of placebo, and then intake of test food after wash out period | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Males and females 20 to 64 years of age
2)Subjects whose fasting blood glucose levels are less than 126 mg/dL 3)Subjects whose HbA1c(NGSP) are less than 6.5% 4)Subjects whose postprandial blood glucose levels at 30 or 60 minutes after 200g rice ingestion are more than 140 mg/dL 5)Subjects whose postprandial blood glucose levels at 120 minutes after 200g rice ingestion are less than 200 mg/dL 6)Subjects who consent to participate in the study, and can sign the consent form |
|||
| Key exclusion criteria | 1)Subjects who has serious medical history or who had digestive tract resection surgery
2)Subjects who routinely use medicine, supplements, FOSHU, and/or health food which affect to result of the study 3)Subjects who have allergy to the test food or rice 4)Subjects who are planning to become pregnant after informed consent for the current study or are pregnant or lactating 5)Heavy use of alcohol or excessive smokers 6)Subjects who is considered to be inappropriate to attend the present study by the investigator |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Kei Yui |
| Organization | FANCL Corporation |
| Division name | Research Institute |
| Address | 12-13, Kamishinano, Totsuka-ku, Yokohama, Kanagawa |
| TEL | 045-820-3755 |
| ke-yui@fancl.co.jp | |
| Public contact | |
| Name of contact person | Reiko Naito |
| Organization | Kenkoin Medical corporation foundation |
| Division name | Kenkoin Clinic |
| Address | 6-7-4, Ginza, Chuo-ku, Tokyo, Japan |
| TEL | 03-3573-1153 |
| Homepage URL | |
| reiko-naito@kenkoin.jp | |
| Sponsor | |
| Institute | FANCL Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | FANCL Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 医療法人財団健康院 健康院クリニック |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039215 |